Patent · US Active

Modified alginates for anti-fibrotic materials and applications

US11090413B2 · kind B2 · utility

2Cited by

17References

25Claims

0Family size

Assignees

Inventors

Arturo Jose Vegas · Belmont, US
Joshua C. Doloff · Quincy, US
Omid Veiseh · Bellaire, US
Minglin Ma · Ithaca, US
Robert S. Langer · Newton, US
Daniel Griffith Anderson · Framingham, US

Key dates

Filing date	Feb 28, 2019
Grant date	Aug 17, 2021
Priority date	—
Expiry date	Feb 28, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N5/0677
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.